Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
University College London · Translational Research Institute for Metabolism and Diabetes · +17 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
252
total citations
- FWCI
- 79.05
- Percentile
- 100%
- References
- 33
Citations per year
Authors
19Topics & keywords
Topics
Keywords
- Semaglutide
- Heart failure with preserved ejection fraction
- Medicine
- Heart failure
- Cardiology
- Internal medicine
- Ejection fraction
- Placebo
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.